MetaCap

Benitec Biopharma Statistics

NASDAQ: BNTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.92-0.225 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Benitec Biopharma by the numbers

Benitec Biopharma has a market capitalization of $285.9 million based on 36.12M shares outstanding. With trailing EPS of $-1.02, Benitec Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.4% below its 50-day average and 29.9% below its 200-day average.

Average daily trading volume is 174.01K shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BNTC valuation vs. peer median

BNTC compared with the median of 8 peer companies
MetricBNTCPeer medianDifference
Market cap$285.88M$280.69M+2%
Avg. volume174.01K976.07K-82%

Peer median across 8 companies: GLSI, FULC, EVMN, RLMD, SPRY, GALT, VCRE, EBS.

Valuation

Price and trading

Previous close
8.14
Open
8.00
Day range
7.75 – 8.16
52-week range
7.72 – 14.39
52-week change
-40.31%
Beta
—
Volume
268.68K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
285.88M
Forward Pe
-0.84
Eps
-1.02
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.39
Week52 Low
7.72
Avg Volume
174.01K
Shares Outstanding
36.12M
Ma50
9.25
Ma200
11.28
Earnings Date
Nov 13, 2026
Pct From52w High
-45.00%
Pct From52w Low
2.53%

Related